61 – 70 of 134
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Diffuse alveolar damage patterns reflect the immunological and molecular heterogeneity in fatal COVID-19
- Contribution to journal › Article
-
Mark
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome : No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
- Contribution to journal › Article
-
Mark
Differential Bias for Creatinine- and Cystatin C- Derived Estimated Glomerular Filtration Rate in Critical COVID-19
- Contribution to journal › Article
-
Mark
Low numbers of COVID-19 in Swedish pediatric oncology patients during the first pandemic year despite an open society
- Contribution to journal › Article
-
Mark
Low Prevalence of Mild Alpha-1-Antitrypsin Deficiency in Hospitalized COVID-19-Patients
- Contribution to journal › Article
-
Mark
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study
- Contribution to journal › Article
-
Mark
Genetic Landscape of the ACE2 Coronavirus Receptor
- Contribution to journal › Article
-
Mark
COVID-19 Modeling Outcome versus Reality in Sweden
- Contribution to journal › Article
-
Mark
Thromboembolic Disease in Patients With Cancer and COVID-19 : Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art
- Contribution to journal › Scientific review
-
Mark
Willingness-to-pay for COVID-19 vaccine in ten low-middle-income countries in Asia, Africa and South America: A cross-sectional study
- Contribution to journal › Article
